Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Vulvar Fractionated CO2-Laser Therapy With and Without Concomitant Topical Clobetasol Propionate 0.05% Ointment for Treatment of Vulvar Lichen Sclerosus

NCT04951206 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT04951206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04951206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Vulvar Fractionated CO2-Laser Therapy With and Without Concomitant Topical Clobetasol Propionate 0.05% Ointment for Treatment of Vulvar Lichen Sclerosus
Lead sponsor
Medstar Health Research Institute
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2022
Completion date
April 25, 2025
Enrollment
212 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

vulvar lichen sclerosus